Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - John C . Morris, M.D.

Back to Research Profile

  1. Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter. Mol Ther 2009 Sep 22. [Epub ahead of print]
    View PubMed
  2. Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol (Oxf) 2009 May; 70(5):671-3. Epub 2009 Feb 17.
    View PubMed
  3. Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate 2009 Jan 1; 69(1):82-91.
    View PubMed
  4. Trujillo MA, Oneal MJ, Davydova J, Bergert E, Yamamoto M, Morris JC 3rd. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer. Breast Cancer Res 2009; 11(4):R53. Epub 2009 Jul 27.
    View PubMed
  5. Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Goke B, Morris JC, Spitzweg C. The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. Eur J Nucl Med Mol Imaging 2008 Jul; 35(7):1272-81. Epub 2008 Apr 11.
    View PubMed
  6. Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, Sebo TJ, Morris JC 3rd. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract 2008 May-Jun; 14(4):426-31.
    View PubMed
  7. Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat 2008 May; 109(2):263-72. Epub 2007 Jul 18.
    View PubMed
  8. Willhauck M, Samani BS, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Goke B, Morris J, Spitzweg C. alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther 2008 Feb; 15(3):214-23.
    View PubMed
  9. Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Goke B, Morris JC, Spitzweg C. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther 2008 Feb; 15(3):214-23. Epub 2007 Nov 08.
    View PubMed
  10. Khoo TK, Hallanger-Johnson J, Baker CH, et al. Comparison of ultrasound-guided fine-needle aspiration biopsy to core-needle biopsy in the evaluation of thyroid nodules. Endocrine Practice 2008; 14:426-431.
    View PubMed
  11. Rao VP, Miyagi N, Ricci D, Carlson SK, Morris JC 3rd, Federspiel MJ, Bailey KR, Russell SJ, McGregor CG. Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation. Transplantation 2007 Dec 27; 84(12):1662-6.
    View PubMed
  12. Willhauck MJ, Samani BRS, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Goke B, Morris JC, Spitzweg C. Application of (188)Rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. Journal of Clinical Endocrinology & Metabolism 2007 Nov; 92(11):4451-8.
    View PubMed
  13. Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum Gene Ther 2007 Oct; 18(10):916-24.
    View PubMed
  14. Dingli D, Russell SJ, Morris JC. Reporting transgene expression using NIS. J Cell Biochem 2007.
    View PubMed
  15. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther 2006 Jun; 17(6):661-8.
    View PubMed
  16. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2006 Jan-Feb; 8(1):16-23.
    View PubMed
  17. Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab 2006 Jan; 91(1):69-78. Epub 2005 Oct 18.
    View PubMed
  18. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther 2006 Jan; 13(1):60-6.
    View PubMed
  19. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am 2005 Dec; 34(4):973-92, x.
    View PubMed
  20. Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochem Biophys Res Commun 2005 Nov 11; 337(1):22-9.
    View PubMed
  21. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ, Morris JC. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide Imaging and therapy of locally recurrent prostate cancer. Mol Ther 2005 Nov; 12(5):835-41.
  22. Cengic N, Baker CH, Schutz M, Goke B, Morris JC, Spitzweg C. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab 2005 Aug; 90(8):4457-64.
    View PubMed
  23. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin Cancer Res 2005 Feb 15; 11(4):1483-9.
    View PubMed
  24. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Goke B, Morris JC, Spitzweg C. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther 2005 Feb; 12(3):272-80.
    View PubMed
  25. Dingli D, Bergert ER, Bajzer Z, O'connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun 2004 Dec 3; 325(1):157-66.
    View PubMed
  26. Baker CH, Morris JC. The sodium-iodide symporter. Current Drug Targets - Immune Endocrine & Metabolic Disorders 2004 Sep; 4(3):167-74.
  27. Guo J, Pichurin PN, Morris JC, Rapoport B, McLachlan SM. "Naked" deoxyribonucleic acid vaccination induces recognition of diverse thyroid peroxidase T cell epitopes. Endocrinology 2004 Aug; 145(8):3671-8.
    View PubMed
  28. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: Current status and future prospects. Thyroid 2004 Jun; 14(6):424-34.
    View PubMed
  29. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004 Mar 1; 103(5):1641-6. Epub 2003 Nov 06.
    View PubMed
  30. Scholz IV, Cengic N, Goke B, Morris JC, Spitzweg C. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. J Clin Endocrinol Metab 2004 Mar; 89(3):1108-16.
    View PubMed
  31. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC. Effects of reducing the upper limit of normal TSH values. JAMA: Journal of the American Medical Association 2003 Dec 24; 290(24):3195-6.
    View PubMed
  32. Dingli D, Russell SJ, Morris JC 3rd. In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem 2003 Dec 15; 90(6):1079-86.
    View PubMed
  33. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Probasin promoter (ARR(2)YB)-Driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res 2003 Nov 15; 63(22):7840-4.
    View PubMed
  34. Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CYF, Goke B, Morris JC. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endocrinology 2003 Aug; 144(8):3423-32.
    View PubMed
  35. Dobert N, Hamscho N, Bergert ER, Oeschger S, Berner U, Goellner J, Menzel C, Morris JC, Grunwald F. Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression. Nuklearmedizin 2003 Aug; 42(4):N42-4.
    View PubMed
  36. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood 2003 Jul 15; 102(2):489-96. Epub 2003 Mar 20.
    View PubMed
  37. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SKG. Phantoms in the assay tube: Heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003 Jul; 88(7):3069-74.
    View PubMed
  38. Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, Rapoport B, McLachlan SM. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology 2003 May; 144(5):1718-25.
    View PubMed
  39. Spitzweg C, Morris JC. The sodium iodide symporter: its pathophysiological and therapeutic implications [Review]. Clin Endocrinol (Oxf) 2002 Nov; 57(5):559-74.
    View PubMed
  40. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurina O, Morris JC, Rapoport B, McLachlan SM. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid 2002 Sep; 12(9):755-64.
    View PubMed
  41. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002 Sep; 87(9):4154-9.
    View PubMed
  42. Spitzweg C, Morris JC. Sodium Iodide Symporter (NIS) and thyroid. Hormone 2002; 1:22-34.
  43. Morris JC. Surgical treatment of inflammatory disease of the thyroid. Endocr Pract 2002; 8(4):313-4.
    View PubMed
  44. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: Correlation with radioiodine uptake. J Clin Endocrinol Metab 2001 Nov; 86(11):5627-32.
    View PubMed
  45. Harrington KJ, Spitzweg C, Bateman AR, Morris JC, Vile RG. Gene therapy for prostate cancer: current status and future prospects. J Urol 2001 Oct; 166(4):1220-33.
    View PubMed
  46. Pinke LA, Dean DS, Bergert ER, Spitzweg C, Dutton CM, Morris JC. Cloning of the mouse sodium iodide symporter. Thyroid 2001 Oct; 11(10):935-939.
    View PubMed
  47. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CYF, Morris JC. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 2001 Oct; 8(20):1524-1531.
    View PubMed
  48. Smallridge RC, Castro MR, Morris JC, Young PR, Reynolds JC, Merino MJ, Sarlis NJ. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid 2001 Aug; 11(8):795-804.
    View PubMed
  49. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001 Jul; 86(7):3327-3335.
    View PubMed
  50. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens 2001 Apr; 15(4):279-83.
    View PubMed
  51. Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC. Expression of the sodium iodide symporter in human kidney. Kidney Int 2001 Mar; 59(3):1013-23.
    View PubMed
  52. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc 2001 Feb; 76(2):161-8.
    View PubMed
  53. Mitchell AM, Manley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH. Sodium iodide symporter (NIS) gene expression in human placenta. Placenta 2001 Feb-Mar; 22(2-3):256-8.
    View PubMed
  54. Spitzweg C, Bergert ER, Morris JC. Sodium iodide symporter: Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease. Current Opinion in Endocrinology & Diabetes 2001; 8(5):259-265.
  55. Spitzweg C, Morris JC. Approaches to gene therapy with sodium/iodide symporter. Exp Clin Endocrinol Diabetes 2001; 109(1):56-59.
    View PubMed
  56. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 2000 Nov 15; 60(22):6526-30.
    View PubMed
  57. Spitzweg C, Morris JC. The immune response to the iodide transporter. Endocrinology & Metabolism Clinics of North America 2000 Jun; 29(2):389-98, viii.
    View PubMed
  58. Spitzweg C, Heufelder AE, Morris JC. Thyroid iodine transport. Thyroid 2000 Apr; 10(4):321-30.
    View PubMed
  59. Castro MR, Kocher D, Morris JC. An unusual case of inappropriate secretion of thyrotropin: neoplastic or nonneoplastic? Endocr Pract 2000 Jan-Feb; 6(1):29-33.
    View PubMed
  60. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol 1999 Dec; 163(3):495-504.
    View PubMed
  61. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 1999 Nov; 84(11):4178-84.
    View PubMed
  62. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab 1999 Sep; 84(9):3328-35.
    View PubMed
  63. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 1999 Aug; 9(8):821-30.
    View PubMed
  64. Castro MR, Bergert ER, Beito TG, McIver B, Goellner JR, Morris JC. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. J Clin Endocrinol Metab 1999 Aug; 84(8):2957-62.
    View PubMed
  65. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res 1999 May 1; 59(9):2136-41.
    View PubMed
  66. Morris JC. The clinical expression of thyrotropin receptor mutations. Endocrinologist 1998 May; 8(3):195-201.
  67. McIver B, Morris JC. The pathogenesis of Graves' disease. Endocrinology & Metabolism Clinics of North America 1998 Mar; 27(1):73-89.
    View PubMed
  68. Morris JC. Mutations and disorders involving the thyroid iodide transporter--the next wave in thyroid diseases. J Clin Endocrinol Metab 1997 Dec; 82(12):3964-5.
    View PubMed
  69. Raju R, Navaneetham D, Kellermann SA, Freeman SL, Morris JC, McCormick DJ, Conti-Fine BM. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans. J Autoimmun 1997 Oct; 10(5):479-89.
    View PubMed
  70. Morris JC, Bergert ER, Bryant WP. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid 1997 Aug; 7(4):527-34.
    View PubMed
  71. Fu AZ, Morris JC, Ford GC, Nair KS. Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis. Anal Biochem 1997 May 1; 247(2):228-36.
    View PubMed
  72. Campbell RK, Bergert ER, Wang Y, Morris JC, Moyle WR. Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Nat Biotechnol 1997 May; 15(5):439-43.
    View PubMed
  73. Morris JC. Structure and function of the TSH receptor: its suitability as a target for radiotherapy. Thyroid 1997 Apr; 7(2):253-8.
    View PubMed
  74. Porrata LF, Morris JC. 63-year-old woman with fever and right flank pain. Mayo Clin Proc 1996 Oct; 71(10):1011-4.
    View PubMed
  75. Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Endocrinology 1996 Aug; 137(8):3329-39.
    View PubMed
  76. Morris JC. Activating mutations of the thyrotropin receptor--unanswered questions. J Clin Endocrinol Metab 1996 Jun; 81(6):2021-2.
    View PubMed
  77. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology 1995 Oct; 136(10):4415-23.
    View PubMed
  78. Kellermann SA, McCormick DJ, Freeman SL, Morris JC, Conti-Fine BM. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. J Autoimmun 1995 Oct; 8(5):685-98.
    View PubMed
  79. Sheehan MT, Morbeck DE, Bergert ER, McCormick DJ, Milius RP, Morris JC. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists. Pept Res 1995 Sep-Oct; 8(5):264-71.
    View PubMed
  80. Seetharamaiah GS, Wagle NM, Morris JC, Prabhakar BS. Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. Endocrinology 1995 Jul; 136(7):2817-24.
    View PubMed
  81. Nagy EV, Morris JC, Burch HB, Bhatia S, Salata K, Burman KD. Thyrotropin receptor T cell epitopes in autoimmune thyroid disease. Clinical Immunology & Immunopathology 1995 May; 75(2):117-24.
    View PubMed
  82. Levine JA, Morris JC. The use of a football helmet to secure a nasogastric tube. Nutrition 1995 May-Jun; 11(3):285.
    View PubMed
  83. Bryant WP, Bergert ER, Morris JC. Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides. Autoimmunity 1995; 22(2):69-79.
    View PubMed
  84. Wagle NM, Dallas JS, Morris JC, Prabhakar BS. Thyrotropin receptor specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the IgG1 subclass. 6 1995 Endocrinology 13; 136:3461-9.
  85. Bryant WP, Bergert ER, Morris JC. Delineation of amino acid residues with hTSHr 256-275 that participate in hormone binding. J Biol Chem 1994 Dec 9; 269:30935-8.
    View PubMed
  86. Oda RP, Madden BJ, Morris JC, Spelsberg TC, Landers JP. Multiple-buffer-additive strategies for enhanced capillary electrophoretic separation of peptides. J Chromatogr A 1994 Sep 30; 680(1):341-51.
    View PubMed
  87. Dallas JS, Desai RK, Cunningham SJ, Morris JC, Seetharamaiah GS, Wagle N, Goldblum RM, Prabhakar BS. Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. Endocrinology 1994 Mar; 134(3):1437-45.
    View PubMed
  88. Morris JC, Gibson JL, Haas EJ, Bergert ER, Dallas JS, Prabhakar BS. Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides. Autoimmunity 1994; 17(4):287-99.
    View PubMed
  89. Morris JC, Bergert ER, McCormick DJ. Structure-function studies of the human thyrotropin receptor. J Biol Chem 1993 May 25; 268:10900-10905.
    View PubMed
  90. Leinung MC, Bergert ER, McCormick DJ, Morris JC. Synthetic analogs of the carboxyl-terminus of beta-thyrotropin: the importance of basic amino acids in receptor binding activity. Biochemistry 1992 Oct 20; 31(41):10094-8.
    View PubMed
  91. Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC 3rd, Burman KD. Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun 1992 Oct 15; 188(1):28-33.
    View PubMed
  92. Freeman SL, McCormick DJ, Ryan RJ, Morris JC. Inhibition of TSH bio-activity by synthetic beta TSH peptides. Endocr Res 1992; 18(1):1-17.
    View PubMed
  93. Leinung MC, Reed DK, McCormick DJ, Ryan RJ, Morris JC. Further characterization of the receptor-binding region of the thyroid-stimulating hormone alpha subunit: a comprehensive synthetic peptide study of the alpha-subunit 26-46 sequence. Proc Natl Acad Sci U S A 1991 Nov 1; 88(21):9707-11.
    View PubMed
  94. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology 1991 Sep; 129(3):1559-67.
    View PubMed
  95. Charlesworth MC, Bergert ER, Morris JC, McCormick DJ, Ryan RJ. The antigenic structure of the human glycoprotein hormone alpha-subunit: III. Solution- and solid-phase mapping using synthetic peptides. Endocrinology 1991 Jun; 128(6):2907-15.
    View PubMed
  96. Morris JC, McCormick DJ, Ryan RJ. Inhibition of thyrotropin binding to receptor by synthetic human thyrotropin beta peptides. J Biol Chem 1990 Feb 5; 265(4):1881-4.
    View PubMed
  97. Morris JCI, Jiang NS, Hay ID, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyroid-stimulating immunoglobulin activity. J Clin Endocrinol Metab 1988 Oct; 67(4):707-712.
    View PubMed
  98. Morris JC 3rd, Ranganathan G, Hay ID, Nelson RE, Jiang NS. The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 1988 Sep; 123(3):1385-94.
    View PubMed
  99. Morris JC 3rd, Jiang NS, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptor. Endocrinology 1988 Jul; 123(1):456-62.
    View PubMed
  100. Morris JC 3rd, Hay ID, Nelson RE, Jiang NS. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc 1988 Jul; 63(7):707-17.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.